A Novel Orally Bioavailable Inhibitor of Kinase Insert Domain-Containing Receptor Induces Antiangiogenic Effects and Prevents Tumor Growth <b> <i>in Vivo</i> </b>

Laura Sepp‐Lorenzino, Kenneth A. Thomas, Xianzhi Mao et al.|Cancer Research|2004

Cited by 26